Competing-risks analysis for evaluating the prognosis of patients with microinvasive cutaneous squamous cell carcinoma based on the SEER database

[1]  M. Dwyer,et al.  NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  K. Sultanem,et al.  Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review , 2021, Journal of Otolaryngology - Head & Neck Surgery.

[3]  Tao Huang,et al.  Data mining in clinical big data: the frequently used databases, steps, and methodological models , 2021, Military Medical Research.

[4]  S. Mehta,et al.  Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged ≥65 years. , 2021, International journal of epidemiology.

[5]  Ian M. Humphreys,et al.  Socioeconomic Factors Affect Presentation Stage and Survival in Sinonasal Squamous Cell Carcinoma , 2021, The Laryngoscope.

[6]  M. Fujimoto,et al.  Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy , 2021, Cancers.

[7]  E. Dellambra,et al.  Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches , 2021, Biomedicines.

[8]  V. Sondak,et al.  The State of Melanoma: Emergent Challenges and Opportunities , 2021, Clinical Cancer Research.

[9]  N. Treister,et al.  Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival. , 2020, Oral oncology.

[10]  Hua Ling,et al.  Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis , 2020, PloS one.

[11]  V. Kähäri,et al.  Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study , 2020, Acta dermato-venereologica.

[12]  Sung-Bae Kim,et al.  Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01) , 2020, BMC Cancer.

[13]  P. Kent,et al.  A conceptual framework for prognostic research , 2020, BMC Medical Research Methodology.

[14]  Huei-Yang Chen,et al.  A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates , 2020, Archives of Osteoporosis.

[15]  Jun Lyu,et al.  Brief introduction of medical database and data mining technology in big data era , 2020, Journal of evidence-based medicine.

[16]  N. Meyer,et al.  Cutaneous Squamous Cell Carcinoma Tumour Size is Associated with Sentinel Lymph Node Metastasis in a Cohort of 69 Patients. , 2019, Acta dermato-venereologica.

[17]  K. Kitikidou,et al.  Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre , 2019, European Journal of Dermatology.

[18]  C. Schmults,et al.  Cutaneous Squamous Cell Carcinoma. , 2019, Hematology/oncology clinics of North America.

[19]  F. Facchiano,et al.  TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness , 2018, Journal of Experimental & Clinical Cancer Research.

[20]  C. Gross,et al.  Factors Associated With Cancer Disparities Among Low-, Medium-, and High-Income US Counties , 2018, JAMA network open.

[21]  A. Rademaker,et al.  Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) Database , 2018, JAMA surgery.

[22]  E. Kruger,et al.  Socioeconomic determinants as risk factors for squamous cell carcinoma of the head and neck: a case-control study in Iran. , 2018, The British journal of oral & maxillofacial surgery.

[23]  Jonathan R. Clark,et al.  Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma , 2018, Head & neck.

[24]  C. Schmults,et al.  Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. , 2018, Journal of the American Academy of Dermatology.

[25]  J. Eloy,et al.  Do geographic differences or socioeconomic disparities affect survival in sinonasal squamous cell carcinoma? , 2017, International forum of allergy & rhinology.

[26]  P. Ingrand,et al.  Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck. , 2017, European annals of otorhinolaryngology, head and neck diseases.

[27]  Jason P Fine,et al.  Practical recommendations for reporting Fine‐Gray model analyses for competing risk data , 2017, Statistics in medicine.

[28]  P. Blumenfeld,et al.  Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx , 2017, JAMA otolaryngology-- head & neck surgery.

[29]  V. Parekh,et al.  Cutaneous Squamous Cell Carcinoma. , 2017, Clinics in laboratory medicine.

[30]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[31]  N. Scott,et al.  Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[32]  Jeremy MG Taylor,et al.  Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma , 2016, Head & neck.

[33]  Nan Zou Bakkeli.  Income inequality and health in China: A panel data analysis. , 2016, Social science & medicine.

[34]  M. Murad,et al.  Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. , 2016, JAMA dermatology.

[35]  P. Spiess,et al.  Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database. , 2016, Urologic oncology.

[36]  I. Zalaudek,et al.  Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. , 2015, European journal of cancer.

[37]  A. Khachemoune,et al.  Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends , 2015, International journal of dermatology.

[38]  Swee T Tan,et al.  The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma—implications on the T‐classification system , 2014, Journal of surgical oncology.

[39]  H. Comber,et al.  Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention , 2014, The British journal of dermatology.

[40]  S. Nair,et al.  Predictors of prognosis for squamous cell carcinoma of oral tongue , 2014, Journal of surgical oncology.

[41]  Ravi Varadhan,et al.  Model selection in competing risks regression , 2013, Statistics in medicine.

[42]  Randy Gordon,et al.  Skin cancer: an overview of epidemiology and risk factors. , 2013, Seminars in oncology nursing.

[43]  A. Qureshi,et al.  Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. , 2013, JAMA dermatology.

[44]  H. Putter,et al.  Competing risks in epidemiology: possibilities and pitfalls. , 2012, International journal of epidemiology.

[45]  J. Dignam,et al.  The Use and Interpretation of Competing Risks Regression Models , 2012, Clinical Cancer Research.

[46]  Suzanne M Olbricht,et al.  Cutaneous squamous cell carcinoma. , 2008, Advances in dermatology.

[47]  B. Schönfisch,et al.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.

[48]  V. Ficarra,et al.  Prognostic factors in squamous cell carcinoma of the penis , 2007, Nature Clinical Practice Urology.

[49]  Jeffrey E. Lee,et al.  Invasive Squamous Cell Carcinoma of the Skin: Defining a High-Risk Group , 2006, Annals of Surgical Oncology.

[50]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[51]  D. Frankel,et al.  Squamous cell carcinoma of the skin. , 1992, Hospital practice.

[52]  Charles A Enke,et al.  Featured Updates to the NCCN Guidelines , 2013 .

[53]  E. Cohen,et al.  We Can Do Better — Improving the Health of the American People , 2008 .